Pages that link to "Item:Q7819"
Jump to navigation
Jump to search
The following pages link to Third-level subsection in publication (Q7819):
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Section 3.3.1: Screening cases on the day of visit (from DOI: 10.1080/22221751.2020.1735265) (Q8403) (← links)
- Section 3.3.2: Sequential examination of confirmed patients (from DOI: 10.1080/22221751.2020.1735265) (Q8404) (← links)
- Section 3.4.1: Severe type (from DOI: 10.1080/22221751.2020.1735265) (Q8406) (← links)
- Section 3.4.2: Critically ill type (from DOI: 10.1080/22221751.2020.1735265) (Q8407) (← links)
- Section 3.5.1: General treatment (from DOI: 10.1080/22221751.2020.1735265) (Q8409) (← links)
- Section 3.5.2: Oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8410) (← links)
- Section 3.5.3: Antiviral treatment (from DOI: 10.1080/22221751.2020.1735265) (Q8413) (← links)
- Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8414) (← links)
- Section 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265) (Q8415) (← links)
- Section 3.5.6: Empirical antimicrobial therapy (from DOI: 10.1080/22221751.2020.1735265) (Q8416) (← links)
- Section 3.3.1. Nucleic Acids Depletion (from DOI: 10.3390/v12020211) (Q10068) (← links)
- Section 3.3.2. Hybridization-Based Enrichment (from DOI: 10.3390/v12020211) (Q10069) (← links)
- Section 3.3.3. Target Amplification (from DOI: 10.3390/v12020211) (Q10070) (← links)
- Section 3.1.1: Myocardial Injury and Heart Failure (from DOI: 10.1007/s11886-020-01293-2) (Q10990) (← links)
- Section 3.1.2: Arrhythmia (from DOI: 10.1007/s11886-020-01293-2) (Q10991) (← links)
